Belisari, A., Iannazzo, S., Di Pasquale, G., Fresco, C., Mantovani, L. G., Ruggeri, M. P., … Landolfi, R. (2016). [Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways, 17(2), 47–58. https://doi.org/10.7175/fe.v17i2.1243